Name: UMIN ID:
Unique ID issued by UMIN | UMIN000025947 |
---|---|
Receipt number | R000029783 |
Scientific Title | Phase I/II multicenter trial of paclitaxel, ramucirumab and nivolumab for metastatic gastric cancer patients who progressed on chemotherapy with fluoropyrimidine plus platinum |
Date of disclosure of the study information | 2017/02/03 |
Last modified on | 2021/08/09 18:12:32 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/02/01 12:35:25 | ||
2 | Update | 2020/02/05 10:26:11 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of person sending information Name of person sending information Organization Organization Organization Organization Address Address Tel |
|
3 | Update | 2020/02/05 10:33:47 | Recruitment status Date of IRB Last follow-up date |
|
4 | Update | 2020/08/05 13:18:41 | Email |
|
5 | Update | 2021/08/09 16:59:05 | Recruitment status Date analysis concluded |
|
6 | Update | 2021/08/09 18:12:32 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |